Molecular biological method capable of detecting low-concentration harmful bacteria in sample

A molecular biological method using centrifugation and PCR with specific primers effectively detects trace harmful bacteria in cosmetic samples, addressing detection challenges and enhancing safety and quality control.

WO2026235401A1PCT designated stage Publication Date: 2026-11-12COSMAX INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
PCT/KR2026/095622
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-05-08
Filing Date
2026-04-07
Publication Date
2026-11-12

AI Technical Summary

Technical Problem

Current methods struggle to accurately detect trace amounts of harmful bacteria in cosmetic samples due to concentration differences with beneficial bacteria, posing a risk to product safety and quality control.

Method used

A molecular biological method involving centrifugation, supernatant recovery, and PCR using harmful bacteria-specific primers to enhance detection sensitivity.

Benefits of technology

Enables accurate detection of trace harmful bacteria even at concentrations 100 million times lower than beneficial bacteria, ensuring product safety and quality control in cosmetics.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure KR2026095622_12112026_PF_FP_ABST
    Figure KR2026095622_12112026_PF_FP_ABST
Patent Text Reader

Abstract

One aspect of the present disclosure relates to a method for detecting trace amounts of harmful bacteria at a concentration of 1:10-8 contained in a high-concentration lactic acid bacteria sample. The method may be a method for detecting harmful bacteria in a cosmetic sample, the method comprising: (a) centrifuging a cosmetic sample; (b) recovering a portion of a supernatant including a cell pellet from the centrifuged sample of step (a); and (c) extracting DNA from the sample recovered in step (b) and performing PCR using a harmful bacteria-specific primer.
Need to check novelty before this filing date? Find Prior Art

Description

Molecular biological methods capable of detecting low concentrations of harmful bacteria in a sample

[0001] This relates to a molecular biological method capable of detecting low concentrations of harmful bacteria in a sample.

[0002] As the importance of the skin microbiome has recently been highlighted in the cosmetics industry, research results are continuously being reported indicating that cosmetics containing beneficial skin bacteria are effective in improving skin condition.

[0003] However, a problem exists in that during the manufacturing process of cosmetics using bacterial strains, harmful skin bacteria, along with beneficial skin bacteria, can be unintentionally introduced and cultured together within the cosmetic composition. In particular, given the current level of technology, it is difficult to detect trace amounts of harmful bacteria due to concentration differences when small amounts of harmful bacteria are present in compositions containing high concentrations of beneficial skin bacteria.

[0004] Therefore, in order to safely utilize strains as materials in the cosmetics industry, there is an urgent need to develop high-sensitivity molecular biological techniques capable of accurately and rapidly detecting trace amounts of contaminants present in products.

[0005] Accordingly, the inventors have completed the present invention by developing a highly sensitive molecular biological method capable of detecting trace amounts of harmful bacteria in microbial culture samples. This is expected to make a groundbreaking contribution to improving quality control and ensuring product safety for cosmetics containing beneficial skin bacteria.

[0006] One aspect provides a method for detecting harmful bacteria in a cosmetic sample, comprising: (a) centrifuging a cosmetic sample at 8,000 to 20,000 rpm; (b) recovering a portion of the supernatant containing a cell pellet from the centrifuged sample of step (a); and (c) extracting DNA from the sample recovered in step (b) and then performing PCR using a primer specific to harmful bacteria.

[0007] Another aspect is to provide a kit for detecting harmful bacteria in cosmetic samples containing harmful bacteria-specific primers.

[0008] Another aspect is to provide a composition for detecting harmful bacteria in cosmetic samples, comprising a harmful bacteria-specific primer.

[0009] Another aspect is to provide a use of a composition comprising a harmful bacteria-specific primer for detecting harmful bacteria in cosmetic samples.

[0010] Another aspect provides a method for providing information regarding whether a cosmetic sample is contaminated with harmful bacteria, comprising: (a) centrifuging a cosmetic sample at 8,000 to 20,000 rpm; (b) recovering a portion of the supernatant containing a cell pellet from the centrifuged sample of step (a); and (c) extracting DNA from the sample recovered in step (b) and then performing PCR using a primer specific to harmful bacteria.

[0011] One aspect provides a method for detecting harmful bacteria in a cosmetic sample, comprising: (a) centrifuging a cosmetic sample at 8,000 to 20,000 rpm; (b) recovering a portion of the supernatant containing a cell pellet from the centrifuged sample of step (a); and (c) extracting DNA from the sample recovered in step (b) and then performing PCR using a primer specific to harmful bacteria.

[0012] The above cosmetic sample (test sample) refers to any sample containing a strain. The above cosmetic sample may refer to a sample in which the type or number of strains contained within the cosmetic sample is unknown. The above cosmetic sample may be used interchangeably with 'sample', 'lactic acid bacteria culture', 'microbial mixed culture', 'strain mixed culture', etc.

[0013] The above cosmetic sample may include a microbial culture sample, a skin beneficial bacteria culture sample, a lactic acid bacteria culture sample, or a cosmetic composition sample.

[0014] The above cosmetic sample may be a lactic acid bacteria culture solution.

[0015] The above cosmetic sample may include a microbial culture containing various strains, specifically a microbial culture containing skin beneficial bacteria or skin harmful bacteria, more specifically a microbial culture containing lactic acid bacteria or harmful bacteria, and most specifically a microbial culture containing Lactobacillus gensenii strain or Staphylococcus aureus strain.

[0016] The above sample contains 1:10 harmful bacteria in the lactic acid bacteria culture solution. -9 Up to 1:10 9 , for example, 1:10 -8 Up to 1:10 8 , 1:10 -8 Up to 1:10 7 , 1:10 -8 Up to 1:10 6 , 1:10 -8 Up to 1:10 5 , 1:10 -8 Up to 1:10 4 , 1:10 -8 Up to 1:10 3 , 1:10 -8 Up to 1:10 2 , 1:10 -8 Up to 1:10 1 , or 1:10 -8 It may be included with a concentration difference of 1:1. If it falls outside the above range, the concentration of one strain in the sample becomes very high and forms a dominant species, so there may be a problem in that the detection of other strains in the sample is inaccurate.

[0017] The above culture medium may refer to an entire medium containing the strain, its metabolites, excess nutrients, etc., obtained by culturing the strain for a certain period in a medium capable of supplying nutrients so that the strain can grow and survive in a test tube. The above culture medium may include a liquid or solid medium. Additionally, the above culture medium may refer to a cell culture medium obtained by culturing the strain, and may refer to a culture medium that includes or excludes the strain.

[0018] The above culture medium may include the culture medium itself obtained by culturing the strain, a concentrate thereof, or a freeze-dried product. Additionally, it may refer to a cosmetic composition, a topical skin preparation composition, a food composition, a pharmaceutical composition, etc., containing the above culture medium.

[0019] The above method may be a method for detecting skin harmful bacteria contained in a cosmetic composition containing skin beneficial bacteria or skin harmful bacteria, and specifically, may be a method for detecting skin harmful bacteria contained in a cosmetic composition containing skin beneficial bacteria.

[0020] The above method may be a method for detecting harmful bacteria contained in a cosmetic composition containing lactic acid bacteria or harmful bacteria, and specifically, may be a method for detecting harmful bacteria contained in a cosmetic composition containing lactic acid bacteria.

[0021] The above method may be a method for detecting a Staphylococcus aureus strain contained in a cosmetic composition containing a Lactobacillus genseni strain or a Staphylococcus aureus strain, and specifically, may be a method for detecting a Staphylococcus aureus strain contained in a cosmetic composition containing a Lactobacillus genseni strain.

[0022] The above cosmetic composition may be a cosmetic composition prepared according to methods conventional in the field, in the form of a formulation including a lotion (skin lotion), skin softener, skin toner, astringent, lotion, milk lotion, moisture lotion, nourishing lotion, massage cream, nourishing cream, moisture cream, eye cream, hand cream, foundation, essence, nourishing essence, eye essence, pack, soap, cleansing foam, cleansing lotion, cleansing cream, cleansing water, cleansing oil, cleansing tissue, hand sanitizer, body lotion, body cream, body cleanser, suspension, gel, powder, paste, shampoo, hair essence, treatment, rinse, scalp pack, mask pack or sheet or aerosol composition.

[0023] The aforementioned beneficial skin bacteria refer to microorganisms that have positive effects on skin health among all microorganisms inhabiting the surface of the skin.

[0024] The above skin beneficial bacteria may include lactic acid bacteria.

[0025] The above lactic acid bacteria may include one or more selected from the group consisting of strains of the genus Lactobacillus (Lactobacillus sp.), Lactococcus (Lactococcus sp.), Enterococcus (Enterococcus sp.), Streptococcus (Streptococcus sp.), and Bifidobacterium (Bifidobacterium sp.), specifically may include strains of the genus Lactobacillus, more specifically may include strains of Lactobacillus jensenii, and most specifically may include strains of Lactobacillus jensenii ATCC 25258.

[0026] The aforementioned skin harmful bacteria and skin beneficial bacteria refer to microorganisms among all microorganisms that have a negative effect on skin health.

[0027] The above-mentioned skin harmful bacteria may include one or more selected from the group consisting of Staphylococcus sp., Pseudomonas sp., Candida sp., Esherichi sp., Salmonella sp., and Klebsiella sp., specifically may include Staphylococcus sp., more specifically may include Staphylococcus aureus sp., and most specifically may include Staphylococcus aureus ATCC 25923 sp.

[0028] Step (a) above may mean a step of separating the cell pellet and the supernatant as a pretreatment process for DNA extraction of the strain by centrifuging the cosmetic sample at 8,000 to 20,000 rpm.

[0029] The centrifugation of step (a) above may be performed at 1,000 to 30,000 rpm, for example, 5,000 to 25,000 rpm, 8,000 to 20,000 rpm, 10,000 to 18,000 rpm, 11,000 to 17,000 rpm, 12,000 to 16,000 rpm, 13,000 to 15,000 rpm, or 14,000 rpm. If the range is exceeded, there may be a problem in that the DNA extraction of harmful bacterial strains is insufficient or the DNA is damaged, resulting in inaccurate detection of harmful bacteria in the sample.

[0030] The centrifugation of step (a) above may be performed for 1 minute to 1 hour, for example, 5 minutes to 30 minutes, 10 minutes to 20 minutes, or 15 minutes. If the centrifugation is performed outside the above range, there may be a problem in that the DNA extraction of harmful bacterial strains is insufficient or the DNA is damaged, resulting in inaccurate detection of harmful bacteria in the sample.

[0031] In one embodiment, when DNA is extracted from a sample after centrifuging the sample at 10,000 to 18,000 rpm for 10 to 20 minutes, the ratio of lactic acid bacteria to harmful bacteria is 1:10 -8 Up to 1:10 8 It was confirmed that trace amounts of harmful bacteria can be accurately detected in samples containing the mixture ratio.

[0032] Step (b) above may mean a step of recovering a portion of the supernatant containing a cell pellet from a centrifuged sample, excluding the cell pellet and a portion of the supernatant adjacent to the cell pellet, thereby specifying the sample for DNA extraction as the cell pellet and a portion of the supernatant adjacent to the cell pellet.

[0033] A portion of the supernatant containing the cell pellet may refer to 5 µl to 500 µl, e.g., 10 µl to 400 µl, 30 µl to 330 µl, 50 µl to 300 µl, 100 µl to 250 µl, 150 µl to 200 µl, or 150 µl, which is close to the cell pellet in the supernatant. If the amount falls outside the above range, there may be a problem in that the DNA extraction of harmful bacterial strains is insufficient, resulting in inaccurate detection of harmful bacteria in the sample.

[0034] In one embodiment, when DNA is extracted by recovering 150 to 200 μl of the centrifuged cell pellet and the supernatant adjacent to the cell pellet, the ratio of lactic acid bacteria to harmful bacteria is 1:10 -8 Up to 1:10 8 It was confirmed that trace amounts of harmful bacteria can be accurately detected in samples containing the mixture ratio.

[0035] The above step (c) is a step of extracting DNA from the sample recovered in step (b) and then performing PCR using primers specific to harmful bacteria, wherein PCR is performed using a pair of primers specific to skin harmful bacteria after DNA extraction to specifically amplify the DNA of the skin harmful bacteria to be amplified, and may mean a step of selectively detecting specific skin harmful bacteria.

[0036] The aforementioned skin harmful bacteria and skin beneficial bacteria refer to microorganisms among all microorganisms that have a negative effect on skin health.

[0037] The above primer pair is a short DNA oligonucleotide pair that can bind complementarily to a specific DNA or cDNA target sequence during the PCR process to provide a point where the DNA polymerase begins to synthesize a new DNA strand.

[0038] The above skin harmful bacteria-specific primer pair may include a nucleotide sequence having sequence homology or sequence identity of at least about 90%, at least about 95%, at least about 96%, at least about 97%, at least about 98%, at least about 99%, at least about 99.5%, or at least about 99.9% with SEQ ID NO. 1 or 2.

[0039] After step (c) above, (d) a step of determining that the sample contains skin harmful bacteria when the Ct (Cycle threshold) value based on the PCR result of step (c) above is less than 35 may be further included.

[0040] The above step (d) may be a step of determining that the sample does not contain skin harmful bacteria if the Ct value based on the PCR result is 35 or higher.

[0041] The above Ct value (Cycle threshold) refers to the number of PCR amplification cycles required to exceed the set threshold. The Ct value is inversely proportional to the amount of initial template DNA; a higher Ct value indicates a smaller amount of initial template DNA.

[0042] If the above Ct value is 35 or higher, it means that the amount of initial template DNA is small and cannot be accurately detected, and if the above Ct value is less than 35, it means that the presence of harmful skin bacteria in the sample can be accurately detected.

[0043] The above method may mean a method for detecting trace amounts of harmful bacteria with a concentration difference of 100 million times contained in cosmetic samples by performing PCR for up to 40 cycles, for example, 39 cycles, 38 cycles, 37 cycles, 36 cycles, or 35 cycles.

[0044] In one embodiment, when extracting DNA after pretreatment in which a sample is centrifuged at 10,000 to 18,000 rpm for 10 to 20 minutes and 150 to 200 µl of the cell pellet and the supernatant adjacent to the cell pellet is removed, the ratio of lactic acid bacteria to harmful bacteria is 1:10 -8 Up to 1:10 8 Even in samples containing the mixture ratio, the Ct value was found to be less than 35, confirming that trace amounts of harmful bacteria corresponding to a 100 million-fold difference in concentration within the lactic acid bacteria culture solution can be accurately detected.

[0045] Another aspect provides a kit for detecting harmful bacteria in cosmetic samples containing a harmful bacteria-specific primer.

[0046] The above kit may be used in the following steps: (a) centrifuging a cosmetic sample at 8,000 to 20,000 rpm; (b) recovering a portion of the supernatant containing a cell pellet from the centrifuged sample of step (a); and (c) extracting DNA from the sample recovered in step (b) and then performing PCR using the harmful bacteria-specific primer.

[0047] Another aspect provides a composition for detecting harmful bacteria in cosmetic samples, comprising a harmful bacteria-specific primer.

[0048] Another aspect provides the use of a composition comprising a harmful bacteria-specific primer for detecting harmful bacteria in cosmetic samples.

[0049] Another aspect provides a method for providing information regarding whether a cosmetic sample is contaminated with harmful bacteria, comprising: (a) centrifuging a cosmetic sample at 8,000 to 20,000 rpm; (b) recovering a portion of the supernatant containing a cell pellet from the centrifuged sample of step (a); and (c) extracting DNA from the sample recovered in step (b) and then performing PCR using a primer specific to harmful bacteria.

[0050] In the above aspects, any terms or elements mentioned that are identical to those already mentioned are as stated above.

[0051] One aspect is 1:10 contained in the high-concentration lactic acid bacteria sample -8 This relates to a method for detecting trace amounts of harmful bacteria at a low concentration.

[0052] Figure 1 is a schematic diagram showing a method for preparing mixed culture solutions of Lactobacillus gensenii strains and Staphylococcus aureus strains at various concentrations.

[0053] Figure 2 is a figure showing the results of detecting harmful bacteria in a sample using the method according to Example 1.

[0054] Figure 3 is a figure showing the results of detecting harmful bacteria in a sample using the method according to Comparative Example 1.

[0055] The following examples will be explained in more detail. However, these examples are intended to illustrate one or more specific examples, and the scope of the present invention is not limited to these examples.

[0056] [Example]

[0057] Example 1. Method for detecting low concentrations of harmful bacteria in a high-concentration lactic acid bacteria culture solution

[0058] In order to detect extremely low concentrations of harmful bacteria in a high-concentration lactic acid bacteria culture solution, an experiment was conducted as follows.

[0059] 1-1. Preparation of a Sample of Mixed Culture Solution of Lactic Acid Bacteria and Harmful Bacteria

[0060] Figure 1 is a schematic diagram showing a method for preparing mixed culture solutions of Lactobacillus gensenii strains and Staphylococcus aureus strains at various concentrations.

[0061] Specifically, in order to determine whether Staphylococcus aureus strain could be detected in a mixed culture of the lactic acid bacteria Lactobacillus jensenii (L. jensenii) ATCC 25258 strain and the harmful bacteria Staphylococcus aureus (S. aureus) ATCC 25923 strain, a mixed culture of Lactobacillus jensenii strain and Staphylococcus aureus strain was prepared as follows.

[0062] Lactobacillus gensenii and Staphylococcus aureus strains were incubated until an OD value of 1.0. When the OD value was 1.00, the CFU / ml of each strain from the stock culture medium, Lactobacillus gensenii and Staphylococcus aureus, was diluted to 10 8 It was adjusted to CFU / ml.

[0063] Subsequently, for the preparation of Day 0 samples, the Lactobacillus genseni strain was 10 8Adjust to CFU / ml, and Staphylococcus aureus strain is 10 8 Starting from CFU / ml, serially dilute in 1 / 10 increments to 10 1 Sampling was performed after diluting to CFU / ml and mixing 1ml of each.

[0064] In addition, for the preparation of Day 1 samples, the Lactobacillus genseni strain is 10 8 Adjust to CFU / ml, and Staphylococcus aureus strain is 10 8 Starting from CFU / ml, serially dilute in 1 / 10 increments to 10 1 1 ml of each diluted to CFU / ml was inoculated into 5 ml of MRS medium, and sampling was performed after incubation for 24 hours.

[0065] According to the preparation of the above samples, the mixing ratio of Lactobacillus gensenii strains and Staphylococcus aureus strains ranges from 1:1 to 1:10 with a tenfold difference. -8 Each was vaccinated so that there was a difference up to that point.

[0066] 1-2. DNA extraction after sample pretreatment

[0067] Subsequently, each sample was pretreated and DNA extraction was performed to confirm the presence of harmful bacteria in the mixed culture solution prepared above.

[0068] Specifically, for DNA extraction of each sample, centrifugation was performed at 14,000 rpm at 4°C for 15 minutes. After centrifugation, all supernatant was removed except for 150 to 200 µl of the supernatant located near the cell pellet.

[0069] The supernatant and cell pellet were collected, DNA was extracted using the QIAGEN Microbial DNA kit, and qPCR was performed using primers specific to Staphylococcus aureus strains as shown in Table 1 below.

[0070] [Table 1]

[0071]

[0072] FIG. 2 is a figure showing the results of detecting harmful bacteria in a sample by the method according to Example 1. As a result, as shown in FIG. 2 below, when centrifugation is performed under specific conditions according to the above method and a cell pellet containing a portion of the supernatant is recovered and used, the ratio is 1:10 -8 It was confirmed that the CT value was less than 35 even with differences in concentration, so the 10 contained in the lactic acid bacteria culture solution -8 It was confirmed that even extremely low concentrations of harmful bacteria in CFU / ml can be detected.

[0073] Accordingly, it can be seen that even extremely small amounts of harmful bacteria contained in compositions containing lactic acid bacteria, such as live bacteria cosmetic compositions, can be detected.

[0074] [Comparative Example]

[0075] Comparative Example 1. Case where centrifugation and sample collection conditions were set differently

[0076] The experiment was conducted in the same manner as Example 1, except that in the centrifugation and recovery step of Example 1-2, the centrifugation condition was set to 10,000 rpm and the recovery condition involved removing all of the supernatant and recovering only the cell pellet.

[0077] Figure 3 is a figure showing the results of detecting harmful bacteria in a sample using the method according to Comparative Example 1.

[0078] As a result, as shown in Figure 3 below, in the DNA sample extracted according to the above method, 1:10 -6 It was confirmed that the CT value in the difference exceeded 35, confirming that harmful bacteria contained in the lactic acid bacteria culture solution were not accurately detected.

[0079] In summary, when detecting Staphylococcus aureus strains in a sample containing high concentrations of Lactobacillus genseni strains using a method based on a single aspect, 1:10 -8 Since Staphylococcus aureus strains can be effectively detected even at extremely low concentrations, this is expected to make a groundbreaking contribution to improving quality control and ensuring product stability of cosmetics containing beneficial skin bacteria.

Claims

1. (a) A step of centrifuging a cosmetic sample at 8,000 to 20,000 rpm; (b) a step of recovering a portion of the supernatant containing a cell pellet from the centrifuged sample of step (a); and (c) a step of extracting DNA from a sample recovered in step (b) and then performing PCR using a primer specific to harmful bacteria; comprising a method for detecting harmful bacteria in a cosmetic sample.

2. A method for detecting harmful bacteria in a cosmetic sample according to claim 1, wherein the cosmetic sample is a lactic acid bacteria culture solution.

3. A method for detecting harmful bacteria in a cosmetic sample according to claim 2, wherein the lactic acid bacteria is a strain of the genus Lactobacillus sp.

4. A method for detecting harmful bacteria in a cosmetic sample according to claim 3, wherein the Lactobacillus strain is a Lactobacillus jensenii strain.

5. A method for detecting harmful bacteria in a cosmetic sample according to claim 1, wherein the centrifugation of step (a) is performed at 10,000 to 18,000 rpm.

6. A method for detecting harmful bacteria in a cosmetic sample according to claim 1, wherein the centrifugation of step (a) is performed for 5 to 30 minutes.

7. A method for detecting harmful bacteria in a cosmetic sample according to claim 1, wherein a portion of the supernatant containing the cell pellet is 50 to 300 µl of the cell pellet and the supernatant adjacent thereto.

8. A method for detecting harmful bacteria in a cosmetic sample according to claim 1, wherein the harmful bacteria are skin harmful bacteria.

9. A method for detecting harmful bacteria in a cosmetic sample, wherein, in claim 8, the skin harmful bacteria is a Staphylococcus aureus strain.